Skip to main content

Sensus Healthcare (SRTS) Gets a Buy from Lake Street

Tipranks - Tipranks - Thu May 15, 2025

In a report released today, Ben Haynor from Lake Street maintained a Buy rating on Sensus Healthcare (SRTS – Research Report), with a price target of $13.00. The company’s shares closed yesterday at $4.59.

Confident Investing Starts Here:

Haynor covers the Healthcare sector, focusing on stocks such as Lifeward, Sensus Healthcare, and Owlet. According to TipRanks, Haynor has an average return of -17.5% and a 28.66% success rate on recommended stocks.

Currently, the analyst consensus on Sensus Healthcare is a Moderate Buy with an average price target of $12.50.

See Insiders’ Hot Stocks on TipRanks >>

Based on Sensus Healthcare’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $13.07 million and a net profit of $1.55 million. In comparison, last year the company earned a revenue of $12.57 million and had a net profit of $4.21 million

Read More on SRTS:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).